아시아태평양의 차세대 IVD 시장 : 분석 및 예측(2023-2033년)

The Asia-Pacific Next-Generation IVD Market Expected to Reach $42.35 Billion by 2033

Introduction to Asia-Pacific Next-Generation IVD (In vitro diagnostics) Market

The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033. The emergence of innovative technologies in diagnostics holds promise for revitalizing the growth of the next-generation In Vitro Diagnostics (IVD) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to play pivotal roles in driving this growth, offering fresh opportunities for enhanced disease detection and ultimately transforming patient outcomes.

Market Introduction

The Asia-Pacific (APAC) region is witnessing significant advancements and growth in the Next-Generation In Vitro Diagnostics (IVD) market. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases and infectious ailments necessitates more accurate and efficient diagnostic solutions. Secondly, rapid urbanization and rising healthcare expenditures in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Thirdly, growing awareness among healthcare providers and patients regarding the benefits of personalized medicine and early disease detection is spurring demand for innovative IVD solutions. Additionally, supportive government initiatives aimed at improving healthcare infrastructure and promoting research and development activities further contribute to market growth in the APAC region.

Market Segmentation:

Segmentation 1: by Type

• Core Laboratory Diagnostics
• POC Testing
• Molecular Diagnostics

Segmentation 2: by End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutions
• Other End Users

Segmentation 3: by Country

• Japan
• India
• China
• South Korea
• Australia
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The next-generation IVD market has been extensively segmented on the basis of various categories, such as type, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
  • 1.1.1 Inclusion and Exclusion Criteria
• 1.2 Market Scope
  • 1.2.1 Key Questions Answered in the Report
• 1.3 Research Methodology
  • 1.3.1 Next-Generation IVD Market: Research Methodology
  • 1.3.2 Data Sources
    • 1.3.2.1 Primary Data Sources
    • 1.3.2.2 Secondary Data Sources
  • 1.3.3 Market Estimation Model
  • 1.3.4 Criteria for Company Profiling

2 Market Overview

• 2.1 Introduction
  • 2.1.1 Next-Generation IVD Market Outlook
    • 2.1.1.1 POC-IVD
    • 2.1.1.2 Diagnostic Expenditures
    • 2.1.1.3 Pricing Patterns of Next-Generation IVD
  • 2.1.2 Market Size and Growth Potential
    • 2.1.2.1 Short-Term Impact (2020-2025)
    • 2.1.2.2 Long-Term Impact (2026-2033)
  • 2.1.3 Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
• 2.2 COVID-19 Impact on the Next-Generation IVD Market
  • 2.2.1 Impact on Operations
  • 2.2.2 COVID-19 Impact: Current Scenario of the Market
  • 2.2.3 Pre-COVID Assessment
  • 2.2.4 Post-COVID-19 Market Assessment

3 Industry Analysis

• 3.1 Legal Requirements
  • 3.1.1 Legal Requirements and Framework in Asia-Pacific

4 Next-Generation IVD Market, by Region, $Million, 2022-2033

• 4.1 Overview
• 4.2 Asia-Pacific
  • 4.2.1 Market Dynamics
  • 4.2.2 Market Size and Forecast
    • 4.2.2.1 Asia-Pacific Next-Generation IVD Market (by End User)
    • 4.2.2.2 Asia-Pacific Next-Generation IVD Market (by Type)
      • 4.2.2.2.1 Asia-Pacific Next-Generation Core Laboratory IVD Market, (by Type)
    • 4.2.2.3 Asia-Pacific Next-Generation IVD Market (by Country)
      • 4.2.2.3.1 China
        • 4.2.2.3.1.1 Market Size and Forecast
        • 4.2.2.3.1.1.1 China Next-Generation IVD Market (by End User)
        • 4.2.2.3.1.1.2 China Next-Generation IVD Market (by Type)
      • 4.2.2.3.2 Japan
        • 4.2.2.3.2.1 Market Size and Forecast
        • 4.2.2.3.2.1.1 Japan Next-Generation IVD Market (by End User)
        • 4.2.2.3.2.1.2 Japan Next-Generation IVD Market (by Type)
      • 4.2.2.3.3 India
        • 4.2.2.3.3.1 Market Size and Forecast
        • 4.2.2.3.3.1.1 India Next-Generation IVD Market (by End User)
        • 4.2.2.3.3.1.2 India Next-Generation IVD Market (by Type)
      • 4.2.2.3.4 Australia
        • 4.2.2.3.4.1 Market Size and Forecast
        • 4.2.2.3.4.1.1 Australia Next-Generation IVD Market (by End User)
        • 4.2.2.3.4.1.2 Australia Next-Generation IVD Market (by Type)
      • 4.2.2.3.5 South Korea
        • 4.2.2.3.5.1 Market Size and Forecast
        • 4.2.2.3.5.1.1 South Korea Next-Generation IVD Market (by End User)
        • 4.2.2.3.5.1.2 South Korea Next-Generation IVD Market (by Type)
      • 4.2.2.3.6 Rest-of-Asia-Pacific
        • 4.2.2.3.6.1 Market Size and Forecast
        • 4.2.2.3.6.1.1 Rest-of-Asia-Pacific Next-Generation IVD Market (by End User)
        • 4.2.2.3.6.1.2 Rest-of-Asia-Pacific Next-Generation IVD Market (by Type)

5 Company Profiles

• 5.1 Overview
• 5.2 Next-Generation IVD Market Ecosystem Active Players
• 5.3 Sysmex Corporation
  • 5.3.1 Company Overview
  • 5.3.2 Role of Sysmex Corporation in the Next-Generation IVD Market
  • 5.3.3 Financials
  • 5.3.4 Recent Developments
    • 5.3.4.1 Business Strategies
  • 5.3.5 Analyst Perspective